GenTrust’s Medpace MEDP Stock Holding History

GenTrust’s Portfolio MEDP Stock Details MEDP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-733	Closed	-$352K	–	263
2026 Q1	$352K	Sell	733 -123	-14%	-$63K	0.02%	184
2025 Q4	$481K	Buy	856 +429	+100%	+$244K	0.02%	165
2025 Q3	$220K	Buy	+427	New	+$186K	0.01%	194

Other funds holding MEDP

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

GenTrust's MEDP Position: Q2 2026 in Review

GenTrust sold out of Medpace (MEDP) in Q2 2026, closing a stake of 733 shares — an estimated $352K sold.

GenTrust first reported a position in MEDP in Q3 2025 and held it in 3 quarters. The position peaked at $481K in Q4 2025. 700 funds tracked by Wall St. Rank hold MEDP as of Q2 2026.

GenTrust reported no remaining Medpace position as of Q2 2026 after selling out during the quarter.
GenTrust sold 733 Medpace shares in Q2 2026, an estimated $352K.
GenTrust first reported a position in Medpace in Q3 2025 and held it in 3 quarters.
GenTrust's Medpace position peaked at $481K in Q4 2025.
700 funds tracked by Wall St. Rank held Medpace as of Q2 2026.

Based on GenTrust's 13F filing for Q2 2026, filed 6 Aug 2026.